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Objectives.We sought to analyze in patients with chronic atrial
fibrillation (AF) the change in the intracardiac atrial defibrilla-
tion threshold (ADT) at rest and during exercise, to quantify the
effective risk of low energy endocavitary cardioversion during the
effort and to compare the ADT of chronic and reinduced AF.
Background. Low energy endocavitary cardioversion is a new
alternative to transthoracic shock in patients with chronic AF.
Nevertheless, patient discomfort and possible induction of ven-
tricular arrhythmias should be further evaluated.
Methods. Sixteen patients with chronic AF were included in the
study. Two 6F custom-made catheters (Electro-Catheter, Inc.)
were used for shock delivery and one tetrapolar lead for ventric-
ular synchronization. Without sedation and in a random order,
patients underwent two sequences of shocks to determine the ADT
at rest and during exercise. Exercise was performed isometrically
by the superior limbs. Atrial fibrillation was reinduced by atrial
pacing. After each shock, the patients were requested to grade
their discomfort with a score from 1 to 5. The power of the study
was >90% in detecting a 25% difference in the ADT between
groups.
Results. Patients were classified into two groups: Nine patients
(group A) underwent the first cardioversion during exercise; seven
patients (group B) underwent the first cardioversion at rest. In
total, the mean (6SD) ADT was 6.70 6 1.54 J during exercise and
7.02 6 1.82 J at rest (p 5 0.59). A significantly lower ADT was
observed in the second shock sequence than the first one (6.32 6
2.09 J vs. 7.406 0.87 J, p < 0.05). The discomfort score was 3.256
0.86 at rest and 2.94 6 0.77 during exercise (p 5 0.09). No
complications occurred.
Conclusions. Low energy endocavitary cardioversion is a safe
and effective procedure in patients with chronic AF. Discomfort is
not generally severe enough to result in procedure termination.
The ADT is not influenced by exercise and is higher in chronic
than in reinduced AF.
(J Am Coll Cardiol 1997;29:576–81)
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Low energy intracardiac transcatheter cardioversion of parox-
ysmal and chronic atrial fibrillation (AF) has recently been
proposed as an alternative to transthoracic cardioversion or as
the last possible therapy for patients refractory to external
atrial defibrillation (1–4). Furthermore, an implantable device
for automatic or manual intracardiac atrial cardioversion will
be soon available (5,6), giving rise to several different problems
relating to the stability of the atrial defibrillation threshold
(ADT) and the safety of such a technique if used in an
automatic mode (7).
Recent experimental studies on animals showed that low
energy intracardiac atrial shocks, if well synchronized on the R
wave, can in some instances be dangerous because of the
possibility of inducing ventricular tachyarrhythmias (8). This
phenomenon was observed in the animals when the intracar-
diac shock was synchronized on the R wave with an RR
interval ,300 ms (8).
No human data on this dangerous outcome has yet been
published. The aims of this study were to analyze the change in
the intracardiac ADT at rest and during exercise; to quantify
the effective risk of this procedure in patients with chronic AF
in a specific situation, like the effort during which the higher
level of circulating catecholamines and the presence of shorter
RR intervals could increase the likelihood of generating
malignant ventricular arrhythmias; and to compare the ADT of
chronic and reinduced AF.
Methods
Subjects and study protocol. Sixteen patients with chronic
AF (duration 10 days or more) who were candidates for low
energy intracardiac atrial cardioversion were included in the
study. The clinical data of the patients are reported in Table 1.
The patients’ mean (6SD) age was 63.25 6 9.69 years (range
43 to 78); six of them were men and 10 women; their mean
body weight was 71.88 6 13.56 kg; their mean height was
163.256 9.60 cm; and their mean body surface area was 1.766
0.20 m2. The mean left atrial diameter was 47.13 6 7.11 mm.
The underlying heart disease was valvular disease in nine
patients (56%), hypertension in five (31%) and hyperthyroid-
ism (corrected before the procedure) in two (12%). The mean
From the Department of Heart Disease, San Filippo Neri Hospital; and
*Arrhythmia Control Unit, I Clinica Medica, La Sapienza University, Rome,
Italy.
Manuscript received February 21, 1996; revised manuscript received August
3, 1996, accepted November 12, 1996.
Address for correspondence: Dr. Massimo Santini, Department of Cardiol-
ogy, San Filippo Neri Hospital, Via Martinotti 20, 00135 Rome, Italy.
JACC Vol. 29, No. 3
March 1, 1997:576–81
576
q1997 by the American College of Cardiology 0735-1097/97/$17.00
Published by Elsevier Science Inc. PII S0735-1097(96)00540-2
duration of atrial fibrillation was 169.38 6 229.27 days (range
10 to 960). Ten patients were taking antiarrhythmic drugs
before the intracardiac cardioversion: eight (50%) amiodarone
and two (12%) propafenone (Table 1). All the patients were
fully orally anticoagulated for at least 20 days before the
procedure and did not present at transesophageal echocardi-
ography with auricular thrombi or spontaneous echo contrast
(9,10). Anticoagulant drugs were discontinued at least 2 days
before the procedure and begun again immediately after it and
continued for 1 month.
The study was approved by our Institutional Ethical Com-
mittee, and all the patients gave written informed consent.
Catheter position and shock wave form. Three intracavi-
tary temporary leads were used in each patient. Two 6F
custom-made temporary catheters (Electro-Catheter, Inc.)
were used for the shock and one USCI tetrapolar lead for
ventricular synchronization. The Elecath leads had ten parallel
platinum electrodes 4.5 mm long and separated by 2 mm; the
active surface area was 314.1 mm2. The femoral approach was
used in all the patients for catheter insertion. The first Elecath
lead was positioned under fluoroscopic guidance in the distal
part of the coronary sinus to embrace the left atrium as much
as possible. The second Elecath lead was positioned in the high
right atrium, paying attention to keep the electrodes in contact
with the atrial wall. The third lead was positioned in the right
ventricular apex (Fig. 1). All the catheters were connected to a
Teletronics Guardian implantable defibrillator especially
adapted to receive such catheters. The capacitor size of the
defibrillator was 150 mF. The defibrillator was used manually
instead of automatically. A truncated, biphasic (3 1 3 ms),
exponential wave form was used (11,12). Beginning from 50 V,
the voltage was increased progressively by 50-V increments
until restoration of the sinus rhythm was obtained. All shocks
were separated by an interval of at least 1 min. The voltage,
both the total and delivered energy and the impedance of each
shock were automatically measured by the device. The total
energy was reported in the study.
Cardioversion at rest and during exercise. The patients
were submitted, in a random order, to two sequences of shocks
to determine the ADT—one in the basal condition at rest and
Abbreviations and Acronyms
ADT 5 atrial defibrillation threshold
AF 5 atrial fibrillation
Figure 1. Catheters positioned in the 308 right (left) and left (right)
anterior oblique views before a low energy endocavitary shock. The two
decapolar, large, active surface catheters are positioned in the coronary
sinus and in the right lateral atrial wall, respectively. The tetrapolar USCI
catheter positioned in the right ventricular apex is used for R wave
synchronization.
Table 1. Clinical Data of the Patients
Pt
No.
Age
(yr)/Gender
Height
(cm)
Weight
(kg)
BSA
(m2)
Underlying Heart
Disease
AF Duration
(days)
Left Atrial Diameter
(mm)
Drug Before
DC Shock
1 63/F 164 80 1.86 Valvular disease 10 58 Amio.
2 70/F 168 75 1.84 Hypertension 210 55 Amio.
3 59/F 169 90 2.01 Hyperthyroidism 60 43 None
4 57/F 140 57 1.44 Valvular disease 30 50 None
5 70/M 175 72 1.86 Valvular disease 90 51 Amio.
6 51/F 156 73 1.73 Valvular disease 90 44 Amio.
7 71/F 157 50 1.45 Valvular disease 960 49 None
8 66/F 160 68 1.72 Hyperthyroidism 240 41 None
9 71/M 165 74 1.85 Hypertension 30 29 None
10 43/F 150 58 1.52 Valvular disease 60 48 Propa.
11 73/M 170 62 1.71 Valvular disease 360 58 Propa.
12 48/F 160 58 1.59 Valvular disease 90 49 Amio.
13 61/M 180 105 2.24 Hypertension 150 43 Amio.
14 68/M 168 75 1.84 Hypertension 150 47 Amio.
15 78/M 165 76 1.81 Hypertension 90 46 None
16 63/F 165 77 1.73 Valvular disease 90 43 Amio.
Mean 63.25 163.25 71.88 1.76 169.38 47.13
SD 9.69 9.60 13.56 0.20 229.27 7.11
AF 5 atrial fibrillation; Amio. 5 amiodarone; BSA 5 body surface area; DC 5 direct current; F 5 female; M 5 male; Propa. 5 propafenone; Pt 5 patient.
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one during exercise. Exercise was performed isometrically by
the superior limbs and continued until the heart rate increased
at least 20% compared with the basal condition. The exercise
was repeated for each step of the procedure. After the first
restoration of sinus rhythm, either during exercise or at rest,
AF was induced again by means of burst atrial pacing after
15 min. The induced AF had to be stable for at least 1.5 min
before the initiation of the second series of shocks. About
1.5 min after AF reinduction the cardioversion protocol was
repeated until the ADT was reached.
Neither general anesthesia nor sedation was used in any
patient. Continuous electrocardiographic monitoring and re-
cording were performed immediately before and during each
step of the cardioversion. After each shock the patients were
requested to grade the discomfort with a score from 1 to 5 (15
not felt; 5 5 severe discomfort).
At the end of the procedure a blood sample for creatine
kinase analysis was taken to discover possible cellular damage.
A transthoracic echocardiogram was performed within 24 h
of the procedure to look for pericardial effusion or contractile
defects.
Statistical analysis. Data are presented as mean values 6
SD. When appropriate, the following tests were performed: the
Student paired and unpaired t test; two-way repeated measures
analysis of variance; multifactorial analysis of variance for
repeated measures was adopted for testing the influence of
both sequences of exercises (groups A and B) and sequences of
shocks (first and second shocks) on the defibrillation threshold.
A p value ,0.05 was considered significant. The power of the
study was .90% in detecting a difference in the ADT of 25%
between the groups.
Results
The patients were classified into two groups according to
the assigned order of cardioversion: Group A included nine
patients who underwent the first intracardiac cardioversion
during exercise and the second one at rest. Group B included
seven patients who underwent the first cardioversion at rest
and the second during exercise.
Successful cardioversion of both spontaneous and rein-
duced AF was obtained in all the patients. Figure 2 shows an
example of intracardiac cardioversion at rest and during
isometric exercise in the same patient.
Atrial defibrillation threshold. The principal intracardiac
cardioversion data are reported in Table 2. The mean ADT in
group A was 7.10 6 1.07 J (range 5.7 to 8.3) during exercise
and 6.42 6 1.77 J (range 2.5 to 10) at rest (p 5 0.38); in group
B, the mean atrial defibrillation threshold was 6.19 6 1.97 J
(range 2.5 to 8.3) during exercise and 7.79 6 0.23 J (range 7.7
to 8.3) at rest (p 5 0.06). Regardless of whether the cardio-
version during exercise was performed for the first or the
second time, considering the total group of patients, the mean
ADT was 6.70 6 1.54 J (range 2.5 to 8.3) during exercise and
7.02 6 1.82 J (range 2.5 to 10) at rest (Fig. 3). This difference
was not significant (p 5 0.59).
When comparing the first ADT with the second one in the
total patient group, regardless of exercise or rest conditions, a
significantly lower ADT was observed in the second shock
sequence compared with the first (6.32 6 2.09 J vs. 7.40 6 0.87
J, p , 0.05) (Fig. 4). No difference in the ADT was observed
between the mean ADT value in all patients of group A
(6.76 6 1.77 J) (which included three patients on amiodarone
and one on propafenone) and that in group B patients (6.99 6
1.58 J) (which included five patients on amiodarone and one
on propafenone) (p 5 0.71).
Antiarrhythmic drugs were administered to four patients of
group A (amiodarone in three and propafenone in one) and to
six patients of group B (amiodarone in five and propafenone in
one).
No other significant difference in the ADT appeared,
comparing its value during exercise and at rest when deter-
Figure 2. Example of internal cardioversion at rest and during isomet-
ric exercise in Patient 9. Chronic AF is converted to sinus rhythm by a
7.7-J shock synchronized on the R wave, both at rest (top) and during
exercise (bottom).
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mined with the first series of shocks (7.10 6 1.07 J vs. 7.79 6
0.23 J, respectively, p 5 0.12) or when determined with the
second series of shocks (6.19 6 1.97 J vs. 6.42 6 2.29 J) (p 5
0.06).
Again, no difference was observed when comparing the
exercise ADT during the first sequence of shocks (7.10 6 1.07
J) with the exercise ADT during the second sequence of shocks
(6.19 6 1.97 J) (p 5 0.25), and the rest ADT determined with
the first sequence of shocks (7.79 6 0.23 J) with the rest ADT
determined with the second sequence of shocks (6.426 2.29 J)
(p 5 0.14).
Ventricular rate and RR interval preceding the shocks.
The mean ventricular rate was significantly lower at rest
(83.136 18.61 beats/min) than during exercise (113.756 19.96
beats/min) (p , 0.0001) (Fig. 5).
The mean RR interval preceding the shock was 622.7 6
Figure 3. Difference in ADT between shock delivered at rest and
during exercise. Data are expressed as individual values (continuous
lines) and mean values (thick bars) 6 SD (thin bars). See text for
explanation.
Figure 4. Difference in ADT between the first and second shocks.
Data are expressed as individual values (continuous lines5 rest/stress;
dotted lines 5 stress/rest) and mean values (thick bars) 6 SD (thin
bars). See text for explanation.
Table 2. Intracardiac Cardioversion Data
Pt No. Random
1st Shock 2nd Shock Rest Stress
J Tol. (score) J Tol. (score) J Rate Tol. (score) J Rate Tol. (score)
1 S 5.70 4 6.20 3 6.20 70 3 5.70 120 4
2 R 7.70 3 5.70 3 7.70 120 3 5.70 150 3
3 S 7.70 4 7.70 4 7.70 70 4 7.70 110 4
4 S 7.70 3 4.00 4 4.00 75 4 7.70 100 3
5 R 7.70 3 5.70 3 7.70 100 3 5.70 140 3
6 R 8.30 3 8.30 2 8.30 90 3 8.30 110 2
7 S 5.70 3 2.50 4 2.50 90 4 5.70 110 3
8 S 8.30 4 10.00 5 10.00 110 5 8.30 140 4
9 R 7.70 2 7.70 3 7.70 70 2 7.70 90 3
10 S 7.70 2 5.70 2 5.70 70 2 7.70 110 2
11 R 7.70 2 5.70 2 7.70 90 2 5.70 130 2
12 S 5.70 2 8.30 3 8.30 80 3 5.70 100 2
13 R 7.70 3 2.50 2 7.70 45 3 2.50 70 2
14 S 7.70 3 7.70 4 7.70 70 4 7.70 110 3
15 S 7.70 3 5.70 3 5.70 80 3 7.70 110 3
16 R 7.70 4 7.70 4 7.70 100 4 7.70 120 4
Mean 7.40 3.00 6.32 3.19 7.02 83.13 3.25 6.70 113.75 2.94
SD 0.87 0.73 2.09 0.91 1.82 18.61 0.86 1.54 19.96 0.77
R 5 rest; S 5 stress; Tol. 5 tolerance.
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216 ms. Considering all the 161 shocks given in the total group,
there was no significant difference between the median RR
interval preceding the shocks at rest and during exercise
(654.306 228.68 ms and 591.95 6 218.33 ms, respectively, p 5
0.07).
An RR interval preceding the shock ,300 and 350 ms was
seen only in two and three cases, respectively. Ventricular
synchronization was appropriate in all the 161 shocks given.
Ventricular arrhythmias were not induced in any of the
patients by the intracardiac atrial shocks. As far as patient
discomfort is concerned, the average score of the successful
shocks was 3.25 6 0.86 at rest and 2.94 6 0.77 during exercise
(p 5 0.09). Comparing the mean discomfort score of all the
first sequences of shocks with that of the second ones, no
relevant difference was noted (3.00 6 0.73 during the first and
3.19 6 0.91 during the second sequence of shocks; p 5 0.33).
In this group of patients, the discomfort score was not related
to the ADT. In fact, considering all the 32 sequences of shocks,
the ADT was not different in the five groups identified
according to the tolerance score (score 2: 6.38 6 1.90 J; score
3: 7.11 6 1.04 J; score 4: 6.56 6 2.04 J; p 5 NS between all the
groups).
A pericardial effusion or a contractile deficit was not
discovered in any of the patients by transthoracic echocardi-
ography performed within 24 h of the procedure. No embolic
episodes were observed after the intracardiac cardioversion,
nor was a creatine kinase elevation detected in any patient.
Discussion
The possibility of reconverting paroxysmal and chronic AF
to sinus rhythm by means of low energy intracardiac atrial
cardioversion is a reality (1–4). An implantable atrial defibril-
lator, alone or in combination with a ventricular defibrillator,
will soon be proposed as an alternative to the drug treatment
of recurrent AF (5–7). This gives rise to question of ADT
behavior during daily life activities and the potential danger of
intracavitary atrial shocks to induce ventricular arrhythmias
(8). Furthermore, no data are yet available on ADT changes
during exercise.
Previous studies on low energy intracardiac cardioversion
of AF. Ayers et al. (8) showed, in the sheep, that low energy
intracavitary atrial shocks may induce ventricular fibrillation (2
[0.28%] of the 716 shocks given during AF) if the preceding
cycle length is #300 ms, whereas no episodes of ventricular
fibrillation (of 895 shocks) were induced with a preceding cycle
length .300 ms. Looking more deeply into the Ayers report
(8), we can see that in the sheep model with induced AF,
ventricular fibrillation was induced only by 2 of the total 716
delivered shocks. Both these episodes of ventricular fibrillation
were initiated with a very short cycle length preceding the
shock (198 and 240 ms, respectively).
Murgatroyd et al. (1) recently confirmed, in humans, the
safety of low energy intracardiac cardioversion of paroxysmal
AF by delivering shocks only after RR intervals .500 ms.
Alt et al. (2) had a 91% success rate in restoring sinus
rhythm in 11 patients with chronic AF with a mean energy level
of 3.7 6 1.7 J and without induction of ventricular fibrillation.
Significant differences can be observed among these reports
and our study, as the Ayers (8) and Murgatroyd (1) works
examined only animals and humans with induced AF and
paroxysmal episodes of the arrhythmia, which require much
less energy than chronic fibrillation to be converted to sinus
rhythm. Furthermore, paroxysmal AF usually has a much
higher ventricular rate than the chronic form, and it is there-
fore more probable to find short RR intervals.
General features of our study. We included only chronic
AF, and this may explain the lower mean ventricular rate
either at rest or during isometric exercise and the higher ADT.
The RR interval preceding the shock in our patient group was
,350 ms only in three cases and ,300 ms only in two cases;
therefore, nothing can be stated by this data about the real risk
of inducing ventricular fibrillation in patients with frequently
very short RR intervals. Considering chronic AF, low energy
intracardiac shocks proved to be very effective and safe either
at rest or during exercise. In our study the ventricular rate
increased significantly during exercise,;33%, reaching a mean
value of 113.13 6 20.56 beats/min (Fig. 5).
This means that circulating catecholamines were increased
significantly (13) and that the shocks were given in a situation
potentially at more risk to induce ventricular arrhythmias
(14,15). Nevertheless, in none of the patients was ventricular
arrhythmia induced by the intracavitary shocks.
Difference in ADT in chronic and reinduced AF. As far as
the ADT is concerned, it appeared clear by this study that the
second sequence of shocks—that is, the intracavitary cardio-
version of the reinduced atrial fibrillation—had a significantly
lower ADT (6.32 6 2.09 J) than the first sequence of shocks
Figure 5. Difference in the ventricular rate at rest and during exercise.
Data are expressed as individual values (continuous lines) and mean
values (thick bars) 6 SD (thin bars). See text for explanation.
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(7.406 0.87 J) (p, 0.05) (Fig. 4), regardless of exercise or rest
conditions. This reduction of the ADT can be interpreted as
the result of the new electrophysiologic situation created by the
interruption of the chronic atrial arrhythmia and the creation
of a new induced arrhythmia, which could be considered
halfway between a chronic and a paroxysmal form of AF. In
fact, compared with chronic arrhythmia, the ADT of the
reinduced arrhythmia is, as said earlier, lower. Nevertheless, it
still remains much higher than the ADT usually reported for
the spontaneous paroxysmal episodes (1) or for the pacing-
induced form of AF in patients or animals (16,17) without
previous atrial arrhythmias. It is probable that the anatomic or
at least the electrophysiologic substrate of induced AF in
patients recently reconverted to sinus rhythm from chronic AF
is significantly different from that of similarly induced or
spontaneous paroxysmal AF in a subject usually in sinus
rhythm for long periods of time. Our results are also in
agreement with the study of Wijffels et al. (18). These investi-
gators showed that the electrophysiologic changes related to
the development of sustained AF return to normal values with
time after cardioversion. In their study, after cardioversion of
long-lasting AF, a prolongation of the effective atrial refractory
period and a lengthening of the local fibrillation interval in
reinduced AF were found. This suggests that reinduced AF is
less complex, more organized and probably sustained by a
lower number of electrical circuits than the persistent form.
This could account for the lower ADT of the reinduced AF in
our study. Moreover, Alt et al. (19) showed a more marked
decrease in the ADT from initial to subsequent cardioversion,
but over a much longer period (months).
Effect of exercise on ADT and tolerance score. As far as the
effect of exercise on the ADT is concerned, we could not find
any significant change in the shock energy necessary to restore
sinus rhythm when compared with the rest ADT. Therefore,
the increased circulating catecholamines do not seem to influ-
ence the ADT, but only the atrioventricular conduction (20).
However, there is an apparent trend toward decreased defi-
brillation thresholds during exercise, which could become
significant by extending the study to a larger number of
patients.
The discomfort score given by the patients did not change
significantly between the two sequences of shocks, at rest and
during exercise, or between the first and the second sequence
of shocks. The procedure did not have to be stopped in any of
the patients because of patient intolerance.
Conclusions. The restoration of chronic AF by means of
low energy intracardiac cardioversion is feasible and carries a
success rate of almost 100%. The patients tolerate the proce-
dure sufficiently well without sedation or general anaesthesia,
both at rest and during exercise. The procedure used in
patients with chronic AF is safe both at rest and during
exercise. The ADT of reinduced AF is lower than that of
chronic AF.
Further studies are needed to clarify the risk of low energy
intracardiac cardioversion of paroxysmal AF during exercise.
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